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ARTICLE OPEN
Effectiveness of case ﬁnding strategies for COPD in primary
care: a systematic review and meta-analysis
Shamil MM Haroon1, Rachel E Jordan1, Joanne O’Beirne-Elliman1 and Peymane Adab1
BACKGROUND: Chronic obstructive pulmonary disease (COPD) is widely underdiagnosed, but the most effective approach for
identifying these patients is unknown.
AIMS: The aim of this study was to summarise and compare the effectiveness of different case ﬁnding approaches for undiagnosed
COPD in primary care.
METHODS: A systematic review of primary studies of any design evaluating case ﬁnding strategies for COPD in primary care among
individuals aged ⩾ 35 years with no prior diagnosis was conducted. Medline, Embase and other bibliographic databases were
searched from 1997 to 2013, and methodological quality was assessed using standard tools. Results were described and meta-
analysis of the uptake and yield from different approaches was performed where there was sufﬁcient homogeneity.
RESULTS: Three randomised controlled trials (RCTs), 1 controlled trial and 35 uncontrolled studies were identiﬁed that assessed the
identiﬁcation of new cases of COPD through systematic case ﬁnding. A range of approaches were used including pre-screening
with questionnaires (n= 13) or handheld ﬂow meters (n= 5) or direct invitation to diagnostic spirometry (n= 30). Overall, any
approach identiﬁed more undiagnosed COPD compared with usual care. Targeting those at higher risk (e.g., smokers) and
pre-screening (e.g., using questionnaires) is likely to increase the yield. However, studies were heterogeneous and were limited by a
lack of comparison groups, inadequate reporting and diversity in the deﬁnition of COPD, which limited our ability to draw ﬁrm
conclusions.
CONCLUSIONS: There is extensive heterogeneity among studies evaluating case ﬁnding strategies for COPD, with few RCTs.
Well-conducted RCTs comparing case ﬁnding approaches are needed to identify the most effective target population, recruitment
strategy and screening tests, using a clinical deﬁnition of COPD, and addressing the limitations highlighted in this review. There is
also a need to evaluate the impact of case ﬁnding on clinical care and patient outcomes.
npj Primary Care Respiratory Medicine (2015) 25, 15056; doi:10.1038/npjpcrm.2015.56; published online 27 August 2015
INTRODUCTION
Chronic obstructive pulmonary disease (COPD) is the third leading
cause of mortality,1 an important cause of disability2 and a source
of signiﬁcant healthcare expenditure.3 However, up to
70–90% of the disease burden remains undiagnosed.4 People
with undiagnosed COPD often under-recognise the signiﬁcance of
their symptoms,5 and there is poor awareness of the condition
among the general public.6,7 Clinicians in primary care also
frequently miss opportunities to diagnose COPD.8 Furthermore, a
higher prevalence of undiagnosed COPD has been associated with
higher rates of COPD-related hospitalisations,9 with diagnosis
often being made during an acute hospital admission following an
exacerbation.10 There is now a policy drive to identify undiag-
nosed COPD earlier in the course of the disease.11 However, the
optimal strategy for achieving this remains unknown.12
A systematic review published in 2008 evaluated the effectiveness
of population-based screening for COPD using spirometry but
concluded that this would identify many asymptomatic individuals
with mild-to-moderate airﬂow obstruction, for whom there are
limited therapeutic options.13 However, since then there have been
a large number of studies of potentially more efﬁcient approaches,
including the use of screening questionnaires14 and handheld ﬂow
meters (e.g., Piko-6, Longmont, CO, USA or COPD-6, Buckingham,
UK)15 and more studies seeking individuals with clinical symptoms.
We report a systematic review to identify and compare the
effectiveness (yield) of alternative case ﬁnding approaches for
COPD in primary care.
MATERIALS AND METHODS
Protocol and registration
The protocol for this review was previously published16 and registered on
the PROSPERO register of systematic reviews (CRD42012002074).17
Eligibility criteria
As RCTs were known to be rare, primary studies of any design were sought
that were conducted in primary care (including general practices and
community pharmacies), recruited individuals aged ⩾ 35 years with no
prior diagnosis of COPD (or provided sufﬁcient data to separate out
subjects with previously known and newly diagnosed COPD) and aimed to
detect undiagnosed COPD conﬁrmed by spirometry. Eligible screening
tests included questionnaires, clinical examination, handheld ﬂow
meters, peak ﬂow meters, decision aids/risk prediction models and chest
radiography, either alone or in combination.
Note that there is no clear deﬁnition of the difference between case
ﬁnding and screening. Some authors deﬁne screening as identifying
asymptomatic patients and case ﬁnding as identifying patients with clinical
disease, although the deﬁnition provided by the UK National Screening
Committee includes structured case ﬁnding within screening.18 In this
review, we sought studies that deﬁned COPD using spirometric criteria,
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and draw particular attention to the studies in which the deﬁnition of
COPD additionally incorporated clinical symptoms.
Search strategy
We searched Medline, Embase, CINAHL, Cochrane Central Register of
Controlled Trials (CENTRAL), Database of Abstracts of Reviews of Effects,
HTA Database and NHS Economic Evaluations Database from 1 March 2012
for the previous 15 years and performed an updated search in Medline and
Embase up to December 2013. To identify grey literature, searches were
also performed on Google Scholar, Turning Research into Practice, HTAi
Vortal and DogPile, limited to the ﬁrst 100 articles per search. No language
restrictions were applied (Supplementary Table S1).
Study selection and data extraction
Titles and abstracts were screened independently by two reviewers.
Full-text papers were obtained for all potentially relevant studies, and
the eligibility criteria were applied independently, with disagreements
resolved through discussion. Data were extracted on the characteristics of
the selected population, approaches to recruitment, method of screening,
number of participants newly diagnosed with COPD and numbers who
were eligible, participated in screening and underwent diagnostic
spirometry. In cases in which these data were not provided, we used
information provided in the paper to derive them.
Methodological quality assessment
Included studies were assessed independently by two reviewers against
criteria adapted from the QUADAS-119 and QUADAS-220 checklists, and the
Cochrane risk of bias assessment tool for RCTs.21 Disagreements were
resolved through discussion.
Statistical analysis
Results from comparative studies were described but not suitable for
synthesis. We therefore used data from individual study arms of the trials
together with the non-comparative studies to summarise uptake of tests
and yields. Where there was sufﬁcient methodological homogeneity, these
were combined using random-effects meta-analyses. Forest plots were
constructed to explore between-study heterogeneity in the yield, including
differences in population characteristics, screening tests, diagnostic criteria
and study design. All analyses were performed using Stata version 13.1
(Stata-Corp, College Station, TX, USA) and StatsDirect version 2.7.9
(Altrincham, Cheshire, UK).
RESULTS
Study selection
After removing duplicates, 2,605 citations were identiﬁed and 266
full-text articles were assessed for eligibility (Figure 1). A total of
39 studies were ﬁnally selected, from which 18 were included in
meta-analyses. Studies that did not exclude patients with previously
known COPD, or those that did not provide sufﬁcient data to
separate out new from existing diagnoses of COPD, were excluded.
Overall study characteristics
There were 2 individual RCTs, 1 cluster RCT, 1 non-randomised
controlled trial, 25 single-arm before-after studies and 10 cross-
sectional test accuracy studies (Supplementary Table S2). Most of
them were conducted in general practices (n= 34), two in
community pharmacies and the remaining studies in either a
health screening clinic (n= 1) or unclear primary care setting
(n= 2). They evaluated the use of screening questionnaires
(n= 13), handheld ﬂow meters (n= 5) and direct invitation for
diagnostic spirometry (n= 30). No studies evaluating other
screening tests met the inclusion criteria.
Comparative studies
The comparative studies were highly heterogeneous, with major
differences in trial design and comparators (Table 1). An RCT of
nurse-led case ﬁnding among four general practices in Australia
Figure 1. Article selection.
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showed that using written invitations to attend spirometry led to
2.3% (95% conﬁdence interval (CI) 0.7 to 3.9%) higher yield of new
cases than usual care.22 A cluster RCT in the Netherlands found
that a practice-managed approach was more effective than
patient self-scoring of a respiratory screening questionnaire before
spirometry assessment (difference in yield 0.9% (0.5 to 1.3%)).23
Our own pilot trial comparing postal versus opportunistic
screening using a respiratory questionnaire before diagnostic
spirometry indicated that the former might lead to higher yield.24
However, the study lacked sufﬁcient power to detect signiﬁcant
differences. Finally, a non-randomised trial found that offering
spirometry to patients attending primary care suspected by their
GP to have COPD resulted in a signiﬁcantly higher yield than mass
invitation to people with chronic respiratory symptoms (difference
18.6% (95% CI 12.6 to 24.6%)).25 These comparative studies
suffered from problems of randomisation,22,25 inadequate blind-
ing of assessors to intervention arms22–25 and insufﬁcient clarity
about whether the populations in trial arms were comparable22,23
(Supplementary Table S3). There was too much heterogeneity in
their design and outcomes to combine their results.
Estimating the effect of different case ﬁnding approaches using all
data from uncontrolled studies and single arms of trials
Methodological quality. The majority of included studies were
uncontrolled single-arm studies and were highly heterogeneous.
They generally provided a clear description of recruitment,
selection criteria, characteristics of screened and clinically
assessed participants and how spirometry was performed. Most
of the studies used standard diagnostic criteria for COPD or airﬂow
obstruction as the outcome. However, they often failed to report
the complete eligible population, withdrawals, uninterpretable
and indeterminate test results, participant ﬂow or spirometry
quality control procedures (Figure 2, Supplementary Tables S4a,b).
Recruitment and population selection. Participants were
actively recruited through postal invitations, telephone calls and
advertisements (n= 17 studies), were opportunistically invited at
primary care consultations (n= 17) or were recruited through a
combination of both approaches (n= 2; Table 2, Supplementary
Table S2). Age (usually ⩾ 40 years) and a positive smoking history
were the main eligibility criteria, although more than half of the
studies included never smokers. A small number of studies
speciﬁed additional eligibility criteria including the presence of
respiratory symptoms26–29 or recent acute respiratory infections.30
Screening tests and diagnosis of COPD. Strategies for targeting
those at high risk included using basic patient characteristics only
(e.g., age and smoking status (n= 30)), use of respiratory screening
questionnaires (n= 13) and administration of handheld ﬂow
meters (n= 5) before diagnostic spirometry. Only nine studies
included a clinical component to the case deﬁnition of COPD. All
other studies used a purely physiological deﬁnition of COPD based
on airﬂow limitation, most commonly a forced expiratory volume
in 1 s to forced vital capacity ratio of o70% (FEV1/FVCo0.7;
n= 30). In addition, 13 used pre-bronchodilator spirometry for
diagnosis, although the yields did not seem to signiﬁcantly differ
according to the use of pre- or post-bronchodilator testing.
Yield of new COPD cases with different approaches. Table 2
summarises the characteristics and yield (proportion of new cases)
of all of the included studies for each case ﬁnding approach. With
direct invitation for diagnostic spirometry, the overall proportion
of all eligible subjects newly diagnosed with COPD (as deﬁned by
each study) ranged from 1.7 to 30.5% (18 studies; Table 2,
Supplementary Tables S5 and S6). Most of them had mild-to-
moderate disease, although in some studies a proportion (up to
37.2%) of subjects had severe disease, which may have been
related to the inclusion of a higher proportion of current smokers
and patients with respiratory symptoms. Studies with highest
yields were mainly test accuracy studies (which generally had
higher methodological quality and possibly had more robust
methods for inviting, assessing and following up participants) and
those including only symptomatic patients.
Among 13 studies that tested screening questionnaires before
diagnostic spirometry (Table 2, Supplementary Table S7), the COPD
Diagnostic Questionnaire14 (also referred to as the International
Primary Airways Group Questionnaire and the Respiratory Health
Screening Questionnaire) was most widely evaluated (n=5 studies).
Overall, new cases of COPD ranged from 0.4 to 22.3% of those
eligible, again with the highest yields found in test accuracy studies.
Five (mostly test accuracy) studies evaluated screening with
handheld ﬂow meters before diagnostic spirometry (Table 2,
Supplementary Tables S8 and S9). Overall, the yield ranged from 6
to 20% of those eligible, and all but one recruited patients
opportunistically.
Because of the methodological heterogeneity, it was not
possible to combine studies or draw ﬁrm conclusions, although
incorporating an initial screening test before diagnostic assess-
ment resulted in generally higher yield (percentage diagnosed
with COPD out of all those referred for spirometry was 19–94% for
handheld ﬂow meters, 14.3–42.1% with screening questionnaires
and 4.1–40.2% with no pre-screening).
Exploring the effect of different target populations and
recruitment strategies
We combined the results of studies including ever smokers,
and a further subset among those already reporting respiratory
symptoms because they appeared to be relatively homogeneous.
Figure 2. Quality assessment. '*' indicates only studies evaluating screening questionnaires and/or handheld ﬂow meters.
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Table 2. Studies evaluating spirometry, screening questionnaires and handheld ﬂow meters
Characteristic Range (no. of studies)
Diagnostic
spirometry (n=30)
Screening
questionnaires (n=13)
Handheld
ﬂow meters (n=5)
Study designs RCT 1 1 0
Cluster RCT 0 1 0
Non-randomised trial 1 0 0
Test accuracy study 7 8 4
Single-arm study 21 3 1
Participantsa Screened — 18,932 4,759
Performed spirometry 63,087 8,845 568
Diagnosed with COPD 10,428 1,996 346
Mean age (years) 47.9–65.3 52.3–65.3 52–65
Male (%) 19.6–100 38.1–69 37.7–99.7
Required smoking status Current/ex-smokers 11 7 2
Inc. never smokers 19 6 3
Required respiratory symptoms 5 0 0
Setting General practice(s) 24 12 5
Pharmacies 1 1 0
Other 3 0 0
Not reported 2 0 0
Number of centres 1–821 1–36 3–25
Multicentre 24 12 5
Single centre 2 1 0
Not reported 4 0 0
Recruitment strategy Active 13 6 1
Opportunistic 14 4 3
Active and opportunistic 1 2 1
Not reported 2 1 0
Questionnaires CDQ1 — 6 —
LFQ — 2 —
Not named — 5 —
Common items — —
Age — 11 —
Smoking status — 12 —
Respiratory symptoms — 13 —
Allergies — 7 —
Handheld spirometers
Device Piko-6 — — 4
COPD-6 — — 1
Operator Nurse — — 3
GP — — 1
Not reported — — 1
Use of bronchodilator Pre-bronchodilator — — 3
Post-bronchodilator — — 2
Test threshold FEV1/FEV6o0.7 — — 3
FEV1/FEV6o0.75 — — 1
FEV1/FEV6o0.8 — — 1
Spirometry
Post-bronchodilator 15 10 5
Pre-bronchodilator 13 3 0
Not reported 2 0 0
Deﬁnition of airﬂow obstruction Post-BD FEV1/FVCo0.7 12 9 3
Pre-BD FEV1/FVCo0.7 9 2 0
Post-BD FEV1/FVCoLLN 1 0 0
Pre-BD FEV1/FVCoLLN 1 0 0
Other 7 2 2
Symptoms in deﬁnition of COPD 4 3 0
Spirometry quality control Yes 22 11 2
No 4 2 1
Unclear 4 0 2
Range of results
New COPD cases/eligible subjectsa 1.7–30.5%19 0.4–22.3%8 6–20%3
New COPD cases/no. screened — 1.5–30.0%12 3–20%5
New COPD cases /no. assessed with spirometry 4.1–40.2%30 14.3–42.1%13 19–94%5
Severity of new cases (FEV1% predicted)
b ⩾80% 11.5–86.7% 11.5–51.1% 33.3–64.3%
50–80% 12.9–68.2% 42.8–87.5% 35.7–61.4%
o50% 0–37.2% 5.3–37.2% 0–16.2%
Abbreviations: BD, bronchodilator; CDQ, COPD Diagnostic Questionnaire (also referred to as the Respiratory Health Screening Questionnaire and the
International Primary Airways Group Questionnaire); COPD, chronic obstructive pulmonary disease; FEV1, forced expiratory volume in 1 s; FVC, forced vital
capacity; LFQ, Lung Function Questionnaire; LLN, lower limit of normal; RCT, randomised controlled trial.
aA number of studies did not report the total eligible population.
bRestricted to studies that reported severity staging according to the Global Initiative for Obstructive Lung Disease (GOLD) strategy.16
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Uptake of screening/diagnostic tests
Opportunistic invitation of ever smokers at routine primary care
attendances was associated with a signiﬁcantly higher uptake of
spirometry (97% (95% CI 90 to 100%); n= 5 studies28,31–34) than
actively inviting ever-smoking patients by post (47% (16 to 80%);
n= 6 studies22,30,35–38), although CIs were wide (which may reﬂect
heterogeneity in the populations being studied). Meta-analysis
(n= 4 studies23,24,35,39) showed an average response to postal
questionnaires of 30% (95% CI 20 to 41%). There were insufﬁcient
data to estimate the response when questionnaires were
distributed opportunistically at primary care attendances and to
estimate the overall yield from either approach.
Target populations
From four similar studies, in which ever smokers aged ⩾ 40 years
were opportunistically invited directly for diagnostic spirometry,
20% (95% CI 7 to 37%;31,33,40,41) were diagnosed with airﬂow
obstruction (Figure 3), although CIs were wide and not all would
necessarily have clinical disease. Restricting recruitment to ever
smokers attending primary care and reporting a history of
respiratory symptoms/infections provided a higher yield of 32%
(95% CI 21 to 44%; n= 3 studies27,28,42), although again these CIs
were wide.
DISCUSSION
Main ﬁndings
This review incorporated evidence from 39 primary studies. The
few comparative studies had a number of methodological
limitations and were highly heterogeneous. They suggested that
active case ﬁnding was likely to identify a greater number of
patients with undiagnosed COPD compared with usual care,22 that
scoring of screening questionnaires before diagnostic assessment
should be practice-led rather than patient-led23 and that
assessment of patients clinically suspected to have COPD is likely
to result in higher yield than widespread invitation of the general
public for screening.25 The remaining studies were non-
comparative, with signiﬁcant limitations in study design and the
reporting of eligible populations, withdrawals, indeterminate
results and spirometry quality control procedures. The lack of
direct comparisons and the heterogeneity in populations, study
design, deﬁnition of COPD and methods for estimating the yield
limited our ability to draw ﬁrm conclusions about the most
effective case ﬁnding approach.
However, indirect comparisons suggested that uptake for
spirometry was higher when patients were invited opportunisti-
cally at routine primary care visits than with active postal
invitation, and response to mailed screening questionnaires is
likely to be ~ 30%. Studies that opportunistically screened ever
smokers with a history of respiratory symptoms seemed to have a
higher yield (although not statistically signiﬁcant) than opportu-
nistic studies among ever smokers in which symptoms were not
considered. Yields from different approaches were highly variable,
although pre-screening using either a questionnaire or handheld
ﬂow meter seemed to achieve a higher yield than direct invitation
for diagnostic assessment. However, no studies had directly
compared questionnaires with the use of handheld devices, nor
considered respective costs. Finally, case ﬁnding is likely to
uncover a signiﬁcant burden of disease, and although the majority
of this will be of mild-to-moderate severity a notable proportion
(410% in several studies) will have severe airﬂow obstruction.
Interpretation of ﬁndings in relation to previously published work
The UK National Screening Committee recently recommended
against screening for COPD because of a lack of relevant RCTs, and
insufﬁcient evidence on the optimal approach and the beneﬁts of
early treatment.12 They also concluded that opportunistic case
ﬁnding among symptomatic individuals with more developed
COPD was likely to be cost-effective and that it should continue.
An older systematic review concluded that mass invitation for
diagnostic spirometry (without prior pre-screening) could not be
recommended, as large numbers of assessments would be
needed to prevent a single COPD exacerbation, and would largely
unveil patients with asymptomatic airﬂow obstruction for whom
there are limited therapeutic options.13 Our ﬁndings concur with
these points but also highlight several important methodological
limitations that should be addressed in future trials evaluating
case ﬁnding strategies. Furthermore, we found that although the
majority of new patients had mild disease (which is arguably when
Figure 3. Random-effects meta-analysis of the proportion of eligible ever smokers diagnosed with COPD when opportunistically invited for
spirometry (restricted to studies that deﬁned airﬂow obstruction as FEV1/FVCo0.7).
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secondary prevention may be most effective) a substantial
proportion of those diagnosed are likely to have moderate-to-
severe disease, with potential to beneﬁt from evidence-based
therapies.43
Jithoo et al.44 recently compared alternative case ﬁnding
strategies, concluding that peak ﬂow meters were a cost-
effective screening test for COPD. However, the peak expiratory
ﬂow rate was derived from quality-controlled spirometry measure-
ments and may not necessarily reﬂect the accuracy of peak ﬂow
meters used in everyday clinical practice. Our search strategy did
not identify studies directly evaluating peak ﬂow meters for case
ﬁnding. RCTs comparing the effectiveness of screening with peak
ﬂow meters against other screening tests such as questionnaires
and handheld ﬂow meters should therefore be considered.
Strengths and limitations of this study
We performed an extensive review of the literature and
incorporated detailed evidence on 39 primary studies. However,
there were very few RCTs, and heterogeneity among those
identiﬁed precluded combining them. We therefore mainly relied
on indirect comparisons, where potential bias arising from
differences in study design and population characteristics made
their combination inappropriate. Missing information on the size
of the eligible population limited estimates of the uptake of
screening and could potentially bias estimates obtained from
meta-analyses. Furthermore, many of the combined results had
wide conﬁdence intervals and should be interpreted with caution.
Unfortunately, with so few RCTs and so many single-arm studies, it
was not possible to undertake the usual statistical analyses to test
for publication bias. However, the search strategy was very
comprehensive, and thus relevant RCTs are unlikely to have been
missed.
Another important limitation was that most studies used a
physiological deﬁnition of COPD based on spirometry, without
clinical conﬁrmation (ascertaining the presence of a compatible
clinical history, including the presence of relevant symptoms). This
is likely to overestimate the effectiveness (yield) of case ﬁnding, as
a previous analysis undertaken by our group45 found that only
about half of the individuals with undiagnosed airﬂow obstruction
reported symptoms compatible with a clinical diagnosis of COPD.
Identiﬁcation of individuals with asymptomatic airﬂow obstruction
is problematic in the absence of evidence-based recommenda-
tions to guide their management.13 In addition, the use of the
ﬁxed ratio for FEV1/FVC is controversial and many people believe
this may also lead to overdiagnosis.46 Conversely, patients with
undiagnosed COPD may underreport symptoms, as they often
adapt to them over time until the quality-of-life is markedly
affected, which may contribute to diagnostic delay.47
Implications for future research, policy and practice
Case ﬁnding through any approach is likely to uncover a
substantial number of patients with undiagnosed COPD. With
the current evidence, it is unclear whether opportunistic or active
case ﬁnding results in a higher overall yield, although targeting
patients with a history of respiratory symptoms or infections
might improve the case ﬁnding yield. Pre-screening using either a
questionnaire such as the COPD Diagnostic Questionnaire or
handheld ﬂow meter may reduce the number of diagnostic
assessments needed compared with directly inviting all high-risk
patients for diagnostic spirometry. However, it is unclear whether
pre-screening with a handheld device would reduce the overall
number of clinical contacts or improve the use of healthcare
resources. Although the majority of patients identiﬁed through
case ﬁnding will have mild-to-moderate disease, around one in
ﬁve is likely to have severe disease with potential to beneﬁt from
being identiﬁed.
At the moment, opportunistic case ﬁnding is recommended as
a cost-effective strategy by the National Institute for Health and
Care Excellence (NICE).48 Our review concludes that focusing case
ﬁnding opportunistically on those at high risk (based on age and
previous smoking history), and reporting relevant clinical symp-
toms, is likely to improve the efﬁciency of case ﬁnding. However,
there is insufﬁcient evidence from well-conducted comparative
studies to suggest which wider screening approach would result
in higher yield, and there is insufﬁcient evidence to support a
more active approach to case ﬁnding.
No further information is needed from single-arm non-
controlled studies. Future studies should directly compare
approaches, particularly addressing how yield could be further
increased by targeting those at highest risk (e.g., by using risk
prediction models), considering alternative recruitment strategies
(opportunistic versus a more active approach for inviting those at
high risk) and alternative screening tests (e.g., questionnaires,
handheld ﬂow meters, peak ﬂow meters and risk prediction
models, alone and in combination).
A deﬁnition of COPD should be used that is standardised
and aligns with current recommendations, requiring clinical
conﬁrmation in addition to airﬂow limitation.11 They should also
report withdrawals and indeterminate results and present this in a
participant ﬂow chart, including a description of the size and
characteristics of the eligible population and those who received a
screening and diagnostic assessment. They should also use strict
quality control procedures for spirometry to avoid misdiagnosis.
The ﬁndings of these studies will be important to enable
economic evaluations of alternative case ﬁnding strategies to
aid policymakers to make appropriate decisions on the most
cost-effective approach.
Conclusions
There is extensive heterogeneity and few RCTs among studies
evaluating case ﬁnding strategies for COPD in primary care, and it
remains unclear as to which approach has the higher overall yield.
Observational studies suggest that targeting speciﬁc sub-groups
such as ever smokers with a history of respiratory symptoms may
be more efﬁcient, and using screening tests such as question-
naires may reduce the number of diagnostic assessments needed
to identify a patient with COPD. High-quality RCTs are needed to
make direct comparisons of alternative case ﬁnding strategies,
including the target population, recruitment strategy and screen-
ing tests, taking into consideration the methodological limitations
of previous studies highlighted in this review. There is currently
inadequate evidence of effectiveness or cost-effectiveness for
recommending any particular approach to case ﬁnding in primary
care. There is also a need to evaluate the impact of case ﬁnding on
clinical care and patient outcomes before ﬁrm recommendations
can be made.
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